Carlsbad, California, October 31, 2014/ Marketwired/- Aurora Spine Corporation announced today the first surgical implant of the company's ZIP ULTRA (TM) Minimally Invasive interspinous device in Israel. "We are very excited that Aurora now offers our ZIP MIS system portfolio in Israel," said Trent Northcutt, President and Chief Executive Officer
CAMBRIDGE, Mass.& STOCKHOLM Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTA?, a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA s review pr
BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today publication of the results of a previous Phase 1/ 2 study for IK-5001, currently named Bioabsorbable Cardiac Matrix, a novel resorbable polymer solution for the prevention of cardiac...
Dublin- Research and Markets has announced the addition of the "Central and South America- Health Insurance, Healthcare and Medical Tourism 2014" report to their offering. Central and South America is an area with a high profile in healthcare, health insurance and medical tourism. Many insurers and the countries themselves, see potential for health
Centric Medical reported that the U.S. Food and Drug Administration has given 510 marketing clearance to its Tarsa- Link system, for internal bone fixation of fractures, fusions, and osteotomies in the foot and ankle. According to a release from the company, Tarsa-Link represents a new osteotomy wedge fusion system and joins Centric Medical's suite
Iatric Systems, Inc., a comprehensive healthcare IT integration company, and its longtime customer Memorial Healthcare today received the 2014 College of Healthcare Information Management Executives Collaboration Award. Memorial Healthcare, based in Owosso, Michigan, and Iatric Systems earned the award by partnering to help the 150- bed hospital en
Release date- 30102014- Cigna Corporation today reported strong third quarter 2014 revenue and earnings results. Consolidated revenues in the quarter were $8.8 billion, an increase of 9% over third quarter 2013. Revenues reflect growth in premiums and fees of 7% in Global Health Care, 17% in Global Supplemental Benefits and 7% in Group Disability a
Data on Telemedicine Described by Researchers at Stanford University. According to news reporting originating in Stanford, California, by NewsRx journalists, research stated, "Telemedicine-based' tele-intensive care unit' solutions represent an increasingly popular hospital platform to provide ICU specialist expertise while remaining sensitive to..
ENP Newswire- 31 October 2014. Release date- 30102014- OSLO, NORWAY- Today, DNV GL announced the launch of its Managing Infection Risk Certification program- a rigorous new initiative aimed at transforming hospitals' processes and approach to mitigating infection risk. 'Every year, about 75,000 hospital patients with healthcare-associated infection
Oct. 31 The Food and Drug Administration has extended its approval of the flu vaccine made by Meriden's Protein Sciences to adults age 50 and older. Making the drug available to older people is important for public health, said Protein Sciences Chief Medical Officer Dr. Protein Sciences makes its vaccines using a modern cell culture technology, w
Dallen Medical reported that the U.S. Food and Drug Administration has granted 510 clearance for its Tensyn Band for acromioclavicular joint and coracoacromial ligament repair in shoulder separation. According to a company release, the Tensyn Band technology, designed for orthopedic surgeons, offers proprietary, knotless banding for stabilized...
Gynesonics reported it has received approval from the U.S. Food and Drug Administration of an investigational device exemption for the pivotal trial, Sonography Guided Transcervical Ablation of Uterine Fibroids, of its newly-designed VizAblate System. "We are pleased to have FDA approval to begin this pivotal trial thus validating the pre-clinical
Republican Andy Tobin and his conservative backers have been attacking Democrat Ann Kirkpatrick for her support of Obamacare. "Fact: Ann Kirkpatrick voted for Obamacare, even though a majority of our district opposes the law," says a post on Tobin's Facebook page. "He fought Medicaid expansion, and 21,000 people in my district just signed up for
By a News Reporter-Staff News Editor at Insurance Weekly News Improved health and more coordinated care for Humana's Medicare Advantage members in Southern California is the goal behind a new fully accountable relationship between Humana Inc. and its provider partners, Greater Newport Physicians and Edinger Medical Group. The new relationship exp
Key Medical Group, Kaweah Delta Health Care District and Humana reported a value-based partnership to improve health and more coordinated care for Humana's Medicare Advantage members in Tulare County. Through Key Medical Group physicians, Humana's Medicare Advantage members will have in-network access to Kaweah Delta facilities, including Kaweah...
RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced today the publication of a peer-reviewed, independent study supporting the importance of mutational profiling in predicting the biologic behavior of pancreatic cysts. Led by researchers from Harbour UCLA Medical Center in Torrance, CA, the study,? strongly support
A retrospective claim analysis utilizing a national database was performed for Commercial insurer, and Medicare databases between January 2000 and March 2011. ". Median ages for patients undergoing penile prosthesis implantation were 58, 70 and 63 years for the Commercial, Medicare and JHH cohorts, respectively. Median time to surgery from initial
Nephros reported that the Company has received 510 clearance from the Food and Drug Administration to market its DSU-H and SSU-H Ultrafilters for use in the hospital setting. "The 510 clearance of our DSU-H and SSU-H Ultrafilters represents a significant step forward in helping hospitals and other healthcare facilities with their infection control
New Pharmaceuticals market report from Global Markets Direct: " Kyorin Pharmaceutical Co., Ltd.- Product Pipeline Review- 2014" Boston, MA 10/31/2014 Global Markets Direct's,' Kyorin Pharmaceutical Co., Ltd.- Product Pipeline Review- 2014', provides an overview of the Kyorin Pharmaceutical Co., Ltd.' s pharmaceutical research and development
New Oral Implant Research Findings Reported from E. Frisch and Co-Authors. By a News Reporter-Staff News Editor at Health& Medicine Week Research findings on Oral Health are discussed in a new report. According to news reporting from Hofgeismar, Germany, by NewsRx journalists, research stated, "Different concepts regarding the number of implants
New Preventive Medicine Study Findings Recently Were Reported by Researchers at Veterans Affairs Medical Center. The news reporters obtained a quote from the research from Veterans Affairs Medical Center, "We used indicators derived from RAND's Quality Assessment Tools and examined percentages of recommended preventive care. For more information on
New Toxicology and Pharmacology Study Findings Have Been Reported by Investigators at MHRA. By a News Reporter-Staff News Editor at Drug Week Research findings on Drugs and Therapies are discussed in a new report. According to news reporting from London, United Kingdom, by NewsRx journalists, research stated, "An international expert group which
Today, DNV GL announced the launch of its Managing Infection Risk Certification program a rigorous new initiative aimed at transforming hospitals processes and approach to mitigating infection risk. Certification programs are commonly available to hospitals for disease-specific care and stroke, but DNV GL s new MIR program represents the first and
Dublin- Research and Markets has announced the addition of the "Process Validation in the US and EU" conference to their offering. The Rembrandt Hotel- London, UK. -Science and Risk Based Approach to Process Validation for Pharmaceutical and Biopharmaceutical Products- Quality Risk Management.
Upon the implementation and throughout the operations and maintenance stages of the system, the system has been referred to as the Chronic Condition Warehouse in common usage and written references. In keeping with this current usage, we will modify the name of this SOR to read, and from this point forward will refer to the system as: " Chronic Con